Business
‘Historic moment’: US regulators approve landmark Alzheimer’s drug – Sydney Morning Herald
The US Food and Drug Administration’s controversial decision delighted advocacy groups but defied the wishes of many top experts…
Washington: US regulators have approved the first ever medication for Alzheimers disease aimed at slowing cognitive decline, a controversial decision that delighted advocacy groups but defied the wishes of many top experts in the field.
The Food and Drug…
Continue Reading
